Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Osteoporosis

Interventions

DRUG

Zoledronic acid

Zoledronic acid per protocol

OTHER

Placebo

All Listed Sponsors

lead

Spokane Joint Replacement Center

OTHER

NCT01267279 - Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter